Virginia BioTechnology Research Park

Virginia Biosciences Commercialization Center

The Virginia Biosciences Commercialization Center (VBCC) develops and leads implementation of tailored commercialization strategies for later-stage bioscience companies looking to launch their product(s) in U.S. markets. This comprehensive program surrounds each company with scientific, clinical and industry experts focused on every facet of the commercialization process, assuring effective scale-up and maximization of enterprise value.  Virginia Life Sciences Investments (VLSI), the Commercialization Center’s parent company, can provide financial support for realization of significant commercialization milestones.

In addition to selecting later-stage, market validated technologies; the Center selects companies focused on specific medical markets. These markets leverage local assets and partnerships, including formal relationships with two of the nation’s largest medical distribution organizations, nationally ranked hospital systems and the resulting clinical experts who are key opinion leaders in their respective fields.

VLSI and VBCC are headquartered at the Virginia BioTechnology Research Park.  For more information on the VBCC and VLSI, visit their website at www.vbcc-inc.com.